Article
Envision Pharma Group
Digital Opinion Leaders: What You Should Know About DOLs
Summary
In this episode, Tom Caravela is joined by Omar McMillan to delve into the emerging role of digital opinion leaders (DOLs) in medical affairs. They explore the criteria for identifying DOLs and their significant impact on the industry. The discussion covers effective strategies for MSLs to engage with DOLs, comparing internal and external management approaches, and providing practical examples. Ethical considerations and the influence of new platforms are examined, along with future predictions for digital engagement. Omar shares valuable advice for MSLs on social media interaction, concluding with a series of thought-provoking questions for listeners.
My guest today is Omar McMillan, MSL Field Director with Genentech shares insights on DOLs and what the Field Medical community should know
Omar discusses…
๐ The criteria that makes a KOL or KTL a “Digital Opinion Leader”
๐ Why DOL’s are relevant and what they mean to the Medical Affairs community
๐ How companies need to designate or categorize certain KOLs as Digital Opinion leaders
๐ The role of the MSL as it relates to DOLs
๐ Advice and Action Items for companies and MSLs
Digital Opinion Leaders, Medical Affairs, MSL engagement strategies, KOL categorization, social media interaction in healthcare
Related Topics
You May Also Like
Envision Pharma Group
Article
Envision Pharma Group
Medical affairs: The power behind redefining commercialization
Podcast
MSL Talk: Tom Caravela, Carsten Schnatwinkel, Jeanna Cooper
The Struggle With KOL Access in Todays World
Podcast
MSL Talk: Tom Caravela, Daniel Snyder
Interim Impact The Rise of Fractional Medical Affairs Roles in Pharmas New Reality
Article
S.F. Oosting, J. Barriuso, A. Bottomley, M. Galotti, B. Gyawali, B. Kiesewetter, N.J. Latino, F. Martinelli, M. Pe, G. Pentheroudakis, F. Roitberg, H. Vachon, E.G.E. de Vries, M. Piccart, N.I. Cherny
Methodological and reporting standards for quality-of-life data eligible for European Society for Medical Oncology-Magnitude of Clinical Benefit Scale
Article
Dylan V Neel, David S Shulman, Clement Ma, Florence Bourgeois, Steven G DuBois